A systematic review of clinical pharmacy services in pediatric inpatients

Author(s):  
Irène Maffre ◽  
Géraldine Leguelinel-Blache ◽  
Ian Soulairol
2020 ◽  
Vol 16 (4) ◽  
pp. 437-449 ◽  
Author(s):  
Thelma Onozato ◽  
Carla Francisca dos Santos Cruz ◽  
Anny Giselly Milhome da Costa Farre ◽  
Carina Carvalho Silvestre ◽  
Rafaella de Oliveira Santos Silva ◽  
...  

2019 ◽  
Vol 28 (3) ◽  
pp. 245-255
Author(s):  
Reyaj Mikrani ◽  
Muhammad Naveed ◽  
Aman Mikrani ◽  
Sufia Yasmeen ◽  
MD. Akabar ◽  
...  

2021 ◽  
Vol 4 (8) ◽  
pp. 994-1010
Author(s):  
Tyler Melton ◽  
Hilary Jasmin ◽  
Haden F. Johnson ◽  
Annika Coley ◽  
Sawyer Duffey ◽  
...  

2018 ◽  
Vol 52 (12) ◽  
pp. 1250-1258 ◽  
Author(s):  
Kyle Strnad ◽  
Bethany R. Shoulders ◽  
Pamela L. Smithburger ◽  
Sandra L. Kane-Gill

Objective: To assess the impact of telepharmacy services in the acute care setting. Data Sources: EMBase, MEDLINE, and SCOPUS database searches were performed through April 2018. Study Selection and Data Extraction: PRISMA guidelines were applied for this systematic review. All English-language studies meeting the criteria of the following population, intervention, comparison, and outcome question were included: What impact does the provision of inpatient clinical pharmacy services delivered via telemedicine have on patient outcomes compared with standard of care? Data Synthesis: A total of 11 studies were identified for the acute care setting, including 3 for critically ill patients. All studies demonstrated a positive impact on patient outcomes, nursing satisfaction, and disease management. Varying modes of telepharmacy technology were used, such as remote access to electronic medical records, faxing or scanning documents, pictures or webcams. For communication purposes, telepharmacists used email or electronic communication, facsimile, video review, or telephone to speak directly with hospital personnel and patients. Relevance to Patient Care and Clinical Practice: Inpatient telepharmacy is feasible and should be leveraged to further enhance patient care by complementing existing service models. Conclusions: Telepharmacy services enhanced patient outcomes, improved nursing satisfaction, and expanded services within inpatient settings. Similar technologies were leveraged in non–intensive care units (ICUs) and ICUs, but the goals of telepharmacy appeared to differ. ICUs focused on an expansion of services in the ICU and non-ICUs addressed improved patient outreach in rural areas.


2019 ◽  
Vol 28 (3) ◽  
pp. 257-258
Author(s):  
Reyaj Mikrani ◽  
Muhammad Naveed ◽  
Aman Mikrani ◽  
Sufia Yasmeen ◽  
MD. Akabar ◽  
...  

BMJ Open ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. e034862 ◽  
Author(s):  
Xue Mi ◽  
Xuelong Su ◽  
Ziyan Jin ◽  
Linan Zeng ◽  
Zhuo Li ◽  
...  

ObjectiveThis article reviewed research conducted on economic evaluations of clinical pharmacy services (CPS) in China. We aimed to identify the types of CPS and the possible economic effects of these services and to hopefully provide some suggestions for designing future economic evaluations of pharmacy interventions in the region.DesignSystematic review.Data sourcesSeveral English databases (PubMed, Embase, The Cochrane Library, National Health Service Economic Evaluation Database), Chinese databases (China National Knowledge Infrastructure, VIP, Chinese Biomedical Literature Database and WanFang Data) and search engines (Google Scholar and BaiDu Scholar) were searched through December 2017.Eligibility criteria for selecting studiesStudies with an economic assessment of CPSs in China were included.Data extraction and synthesisTwo reviewers independently screened the studies, extracted the data, assessed the quality of the included studies and then qualitatively analysed the results.ResultsForty articles were included in the final analysis. Most studies were performed in hospitals and the intervention populations mainly included adults. The types of pharmaceutical services included antimicrobial management, chronic disease state management and multidimensional clinical pharmaceutical services. A positive economic benefit associated with CPS was noted in 80% (n=32) of these articles, showing that CPS were associated with cost savings and improved patient outcomes. However, only three studies were full economic evaluations, using the method of cost-effectiveness analysis.ConclusionCPS was associated with cost savings and generated positive economic value. With the expanding role of pharmacists in the healthcare sector, it is suggested that new pharmaceutical services be used in future studies and that high-quality full economic evaluations capturing both expenses and cost savings be conducted.


2018 ◽  
Vol 25 (1) ◽  
pp. 130-139 ◽  
Author(s):  
Sam Maleki ◽  
Marliese Alexander ◽  
Tsien Fua ◽  
Chen Liu ◽  
Danny Rischin ◽  
...  

Background Patients receiving anticancer therapies are frequently prescribed complex and high-risk medication regimens, which at times can result in medication misadventures. The objective of this review was to assess the effect of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies, including patients undergoing radiotherapy. Methods A systematic review of original publications indexed in EMBASE, MEDLINE and Cochrane Library from June 2007 to June 2017. Eligible studies evaluated outpatient pharmacy clinic services for cancer patients and reported at least one medication-related quantitative outcome measure. Two authors independently reviewed full-text articles for inclusion, then extracted data and performed quality and risk of bias assessments. Results Of 908 identified publications, 13 met predefined eligibility criteria; 1 randomised control trial, 2 controlled cohort studies and 10 uncontrolled before–after studies. Many excluded studies described outpatient pharmacy services but lacked medication-related outcomes. All included studies had informative practice model designs, with interventions for drug-related problems including drug dose optimisation ( n = 8), reduced drug interaction ( n = 6) and adverse drug reaction reporting ( n = 3). Most studies ( n = 11) reported on symptom improvement, commonly nausea ( n = 7) and pain ( n = 5). Of four studies in radiotherapy cohorts, pharmacist involvement was associated with improved symptoms, satisfaction and wellbeing scores. Conclusion Few studies have objectively assessed outpatient pharmacy cancer services, even fewer in the radiotherapy settings. Although the results support these services, significant heterogeneity and bias in the study designs prohibit robust conclusions and further controlled trials are required.


Author(s):  
Irene Park Ulrich ◽  
Brunilda Lugo ◽  
Phillip Hughes ◽  
Lorna Doucette ◽  
Bianca B. Creith ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document